Fiche centre
Policlinico Umberto I
Roma — Italy
Essais liés5clinical trials
VilleRomalocalisation
PaysItalylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT04616326
Essais cliniques associés
5| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| IMPACT STREAM — Master Framework For Relapse or Refractory Acute Myeloid Leukemia | Cancer | À vérifier | NCT06459024 | IMPACT STREAM — Master Framework For Relapse or Refractory Acute Myeloid Leukemia | RECRUITING |
| Galcanezumab | Migraine | Phase 3 | NCT04616326 | REBUILD-2 — A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine | ACTIVE_NOT_RECRUITING |
| Galcanezumab | Migraine | Phase 3 | NCT03432286 | REBUILD-1 — A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine | ACTIVE_NOT_RECRUITING |
| XEN1101 | Épilepsie | Phase 3 | NCT05667142 | X-ACKT — A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures | RECRUITING |
| BLESS — Cenobamate in Adults With Focal-Onset Seizures | Épilepsie | À vérifier | NCT05859854 | BLESS — Cenobamate in Adults With Focal-Onset Seizures | ACTIVE_NOT_RECRUITING |